Summit Securities Group’s Intra-Cellular Therapies Inc. ITCI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-27,500
Closed -$3.63M 1503
2025
Q1
$3.63M Buy
+27,500
New +$3.43M 0.57% 21
2022
Q1
Sell
-1,000
Closed -$52K 1412
2021
Q4
$52K Buy
+1,000
New +$42K ﹤0.01% 726
2020
Q1
Sell
-3,500
Closed -$12M 512
2019
Q4
$12M Hold
3,500
0.91% 24
2019
Q3
$2.62M Buy
+3,500
New +$33.6K 0.23% 71

Other funds holding ITCI